218 related articles for article (PubMed ID: 36087632)
1. Efficacy of SubcutAneous implantable cardioVErter-defibrillators in ≤18 year-old CHILDREN: SAVE-CHILDREN registry.
Mori H; Sumitomo N; Tsutsui K; Fukunaga H; Hayashi H; Nakajima H; Muraji S; Nabeshima T; Kawano D; Ikeda Y; Asano S; Nitta J; Watanabe S; Hokosaki T; Sato S; Chisaka T; Higaki T; Nakajima T; Tamura S; Kaneko Y; Ikeda K; Okada A; Kobayashi H; Motoki H; Minamiguchi H; Imamura T; Shizuta S; Kawamura M; Munetsugu Y; Suzuki T; Murakami T; Horigome H; Wada T; Takamuro M; Ozawa J; Suzuki H; Izumi D; Otsuki S; Chinushi M; Kato K; Miura M; Maeda J; Fukunaga M; Kondo H; Takahashi N; Tobiume T; Morishima I; Kuraishi K; Nakamura K; Hayashi H; Suzuki H; Yoshida Y; Fukamizu S; Hojo R; Nuruki N; Yoshinaga M; Hayashi K; Fukaya H; Kishihara J; Kobayashi T; Kato R
Int J Cardiol; 2023 Jan; 371():204-210. PubMed ID: 36087632
[TBL] [Abstract][Full Text] [Related]
2. Appropriate and inappropriate shocks in hypertrophic cardiomyopathy patients with subcutaneous implantable cardioverter-defibrillators: An international multicenter study.
Nazer B; Dale Z; Carrassa G; Reza N; Ustunkaya T; Papoutsidakis N; Gray A; Howell SJ; Elman MR; Pieragnoli P; Ricciardi G; Jacoby D; Frankel DS; Owens A; Olivotto I; Heitner SB
Heart Rhythm; 2020 Jul; 17(7):1107-1114. PubMed ID: 32084597
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of subcutaneous implantable cardioverter-defibrillator therapy in patients with Brugada syndrome.
Shinohara T; Abe I; Hirota K; Kondo H; Fukui A; Akioka H; Teshima Y; Yufu K; Nakagawa M; Takahashi N
Heart Vessels; 2021 Feb; 36(2):260-266. PubMed ID: 32833119
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Experience With the Subcutaneous Implantable Cardioverter-Defibrillator in Teenagers and Young Adults.
Bettin M; Larbig R; Rath B; Fischer A; Frommeyer G; Reinke F; Köbe J; Eckardt L
JACC Clin Electrophysiol; 2017 Dec; 3(13):1499-1506. PubMed ID: 29759830
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Clinical Outcomes of Subcutaneous Versus Transvenous Implantable Defibrillator Therapy.
Brouwer TF; Yilmaz D; Lindeboom R; Buiten MS; Olde Nordkamp LR; Schalij MJ; Wilde AA; van Erven L; Knops RE
J Am Coll Cardiol; 2016 Nov; 68(19):2047-2055. PubMed ID: 27810043
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Complications of Subcutaneous versus Conventional Cardioverter Defibrillators: A Systematic Review and Meta-analysis.
Araújo CS; Silva CLB; da Silva Menezes Júnior A; Barbosa VA; de Almeida Laranjeira T; Fernandes JF; Gonçalves LC; Silva AMC
Curr Cardiol Rev; 2022; 18(3):e081221198647. PubMed ID: 34879809
[TBL] [Abstract][Full Text] [Related]
7. Subcutaneous versus transvenous implantable cardioverter defibrillators in children and young adults: A meta-analysis.
Vetta G; Parlavecchio A; Magnocavallo M; Valente D; Caminiti R; Polselli M; Vetta F; Cirone D; Cauti FM; Crea P; Rossi P; Chierchia GB; Bianchi S; de Asmundis C; Natale A; Della Rocca DG
Pacing Clin Electrophysiol; 2022 Dec; 45(12):1409-1414. PubMed ID: 36214206
[TBL] [Abstract][Full Text] [Related]
8. Transvenous and non-transvenous implantable cardioverter-defibrillators in children, adolescents, and adults with congenital heart disease: who is at risk for appropriate and inappropriate shocks?
Krause U; Müller MJ; Wilberg Y; Pietzka M; Backhoff D; Ruschewski W; Paul T
Europace; 2019 Jan; 21(1):106-113. PubMed ID: 30339209
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
Roses-Noguer F; Jarman JW; Clague JR; Till J
Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999
[TBL] [Abstract][Full Text] [Related]
10. Inappropriate shock incidence in patients with subcutaneous implantable cardioverter-defibrillators with concomitant cardiac implantable electronic devices: A single-center cohort study.
Okazaki M; Sahashi Y; Nagase T; Inoue K; Sekiguchi Y; Nitta J; Shinoda S; Shimizu S; Kuroki M; Isobe M; Mihara T
Pacing Clin Electrophysiol; 2024 Jan; 47(1):131-138. PubMed ID: 38010718
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators.
Peterson PN; Greenlee RT; Go AS; Magid DJ; Cassidy-Bushrow A; Garcia-Montilla R; Glenn KA; Gurwitz JH; Hammill SC; Hayes J; Kadish A; Reynolds K; Sharma P; Smith DH; Varosy PD; Vidaillet H; Zeng CX; Normand ST; Masoudi FA
J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29122811
[TBL] [Abstract][Full Text] [Related]
12. Impact of Median Sternotomy on Safety and Efficacy of the Subcutaneous Implantable Cardioverter Defibrillator.
Sugrue A; Ibrahim R; Lu M; Bhatia NK; Alkukhun L; Adewumi J; Schaller RD; Marchlinski FE; D'Souza B; Nazer B; Tzou W; Merchant FM; Frankel DS
Circ Arrhythm Electrophysiol; 2023 Aug; 16(8):468-474. PubMed ID: 37485688
[TBL] [Abstract][Full Text] [Related]
13. Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies.
Brouwer TF; Knops RE; Kutyifa V; Barr C; Mondésert B; Boersma LVA; Lambiase PD; Wold N; Jones PW; Healey JS
Europace; 2018 Sep; 20(FI2):f240-f248. PubMed ID: 29771327
[TBL] [Abstract][Full Text] [Related]
14. Oversensing issues leading to device extraction: When subcutaneous implantable cardioverter-defibrillator reached a dead-end.
Noel A; Ploux S; Bulliard S; Strik M; Haeberlin A; Welte N; Marchand H; Klotz N; Ritter P; Haïssaguerre M; Bordachar P
Heart Rhythm; 2020 Jan; 17(1):66-74. PubMed ID: 31295585
[TBL] [Abstract][Full Text] [Related]
15. The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort.
Olde Nordkamp LR; Dabiri Abkenari L; Boersma LV; Maass AH; de Groot JR; van Oostrom AJ; Theuns DA; Jordaens LJ; Wilde AA; Knops RE
J Am Coll Cardiol; 2012 Nov; 60(19):1933-9. PubMed ID: 23062537
[TBL] [Abstract][Full Text] [Related]
16. The SIDECAR project: S-IcD registry in European paediatriC and young Adult patients with congenital heaRt defects.
Silvetti MS; Bruyndonckx L; Maltret A; Gebauer R; Kwiatkowska J; Környei L; Albanese S; Raimondo C; Paech C; Kempa M; Fésüs G; Knops RE; Blom NA; Drago F
Europace; 2023 Feb; 25(2):460-468. PubMed ID: 36107451
[TBL] [Abstract][Full Text] [Related]
17. Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Meta-Analysis of Case-Control Studies.
Basu-Ray I; Liu J; Jia X; Gold M; Ellenbogen K; DiNicolantonio J; Komócsi A; Vorobcsuk A; Kim J; Afshar H; Lam W; Mathuria N; Razavi M; Rasekh A; Saeed M
JACC Clin Electrophysiol; 2017 Dec; 3(13):1475-1483. PubMed ID: 29759827
[TBL] [Abstract][Full Text] [Related]
18. The need for a subsequent transvenous system in patients implanted with subcutaneous implantable cardioverter-defibrillator.
Gasperetti A; Schiavone M; Vogler J; Laredo M; Fastenrath F; Palmisano P; Ziacchi M; Angeletti A; Mitacchione G; Kaiser L; Compagnucci P; Breitenstein A; Arosio R; Vitali F; De Bonis S; Picarelli F; Casella M; Santini L; Pignalberi C; Lavalle C; Pisanò E; Ricciardi D; Calò L; Curnis A; Bertini M; Gulletta S; Dello Russo A; Badenco N; Tondo C; Kuschyk J; Tilz R; Forleo GB; Biffi M
Heart Rhythm; 2022 Dec; 19(12):1958-1964. PubMed ID: 35781042
[TBL] [Abstract][Full Text] [Related]
19. The subcutaneous implantable cardioverter-defibrillator: A tertiary center experience.
Khazen C; Magnusson P; Flandorfer J; Schukro C
Cardiol J; 2019; 26(5):543-549. PubMed ID: 29718532
[TBL] [Abstract][Full Text] [Related]
20. Primary prevention implantable cardioverter-defibrillators in hypertrophic cardiomyopathy-Are there predictors of appropriate therapy?
Weissler-Snir A; Dorian P; Rakowski H; Care M; Spears D
Heart Rhythm; 2021 Jan; 18(1):63-70. PubMed ID: 32800967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
